Gene Therapy
New Findings from University of Dundee in the Area of Gene Therapy Published
Published in Gene Therapy Weekly, September 22nd, 2011
2011 SEP 22 -- Research findings, "Keratin 14-null cells as a model to test the efficacy of gene therapy approaches in epithelial cells," are discussed in a new report. "Skin fragility disorders caused by keratin mutations are incurable, and a better understanding of their etiology is needed to find new ways to improve and treat these conditions. The best-studied skin fragility disorder is epidermolysis bullosa simplex (EBS), an autosomal dominant condition caused by mutations in keratin 5 (K5) or K14," investigators in Dundee, United Kingdom report.
"To analyze disease mechanisms and develop gene therapy strategies, we have used keratinocyte cell lines...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2011-09-22)
More Articles from Gene Therapy Weekly
- Alzheimer Disease
Data from Nebraska Medical Center Provide New Insights into Alzheimer Disease - Gene Therapy
Data on Gene Therapy Detailed by Researchers at University of Western Australia - Parkinson's Disease
Findings in Parkinson's Disease Reported from University of Lund - Antisense Technology
Hebei Medical University Details Research in Antisense Technology - Small Interference RNAs (siRNAs)
Investigators at Inje University Have Published New Data on Small Interference RNAs (siRNAs) - Life Science Research
Investigators at University of Tokyo Zero in on Life Science Research - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
